+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood



A new beta-2 sympathomimetic drug with longer effectiveness. Comparison with current beta-2 sympathomimetic drugs in therapy of bronchial asthma in childhood



Monatsschrift Kinderheilkunde 141(1): 53-58



Inhaled beta-2-agonists are well established for the treatment of bronchial asthma. Treatment in childhood asthma has to take into account the longer night rests and intensive physical activity of the children. The new inhaled beta-2-agonist Formoterol meets these aspects because of the long lasting efficacy. In addition, compliance is increased by easy handling and rare application. Effects of Formoterol in children derived from several studies are presented. In single dose studies, Formoterol (12, 24 mcg) showed a rapid onset of action and in comparison to salbutamol and fenoterol a four-fold respectively two-fold longer lasting spasmolytic effect. The protective effect against unspecific stimuli was comparable but significantly longer. This protection was even more pronounced with a higher dose (24 micrograms). Long-term studies over three months showed that Formoterol (2 x 12 micrograms/day) improved lung function and asthmatic symptoms and protected against histamine and cold-air challenge throughout the study. Formoterol was well tolerated and additional medication could be reduced. Furthermore, we accomplished a high acceptance of treatment with Formoterol for both children and their parents.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079040

Download citation: RISBibTeXText

PMID: 8095323


Related references

The beta-2-agonist perplexity: pro and contra sympathomimetic drugs in childhood asthma. Agents and Actions. Supplements 40: 191-200, 1993

The effect of a new sympathomimetic beta-receptor stimulating drug (terbutaline) on the pulmonary mechanics in bronchial asthma. Scandinavian Journal of Respiratory Diseases 51(3): 188-194, 1970

Risk-benefit assessment and value of beta-2-sympathomimetic drugs in asthma therapy. Pneumologie 46(8): 315-321, 1992

Influence of different metabolic conditions on the affinity of alpha sympathomimetic and beta sympathomimetic drugs on the rabbit aortic strip. Naunyn-Schmiedeberg's Archives of Pharmacology 282(SUPPL): R78, 1974

Emergency use of sympathomimetic drugs in bronchial asthma and anaphylactic shock in current practice. Allergie et Immunologie (Paris) 20(8): 281, 283-287, 1988

In vitro study of phosphodiesterase-inhibiting drugs: a complement to beta-sympathomimetic drug therapy in premature labor?. American Journal of Obstetrics and Gynecology 145(7): 802-806, 1983

Adrenergic drugs and pharmaco vigilance beta 2 sympathomimetic aerosols in asthma. Allergie et Immunologie (Paris) 20(8): 306, 309, 311, 1988

Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action. General Pharmacology 20(4): 417-419, 1989

The importance of inhalation of beta 2 sympathomimetic drugs in the home care treatment of asthma in children. Annals of Allergy 63(1): 37-38, 1989

Adrenergic therapy and vigilance: beta-2 sympathomimetic aerosols in asthma. Allergie et Immunologie 20(8): 306, 309, 311, 1988

Protective action of blocking of beta-1 adrenergic receptors against cardio-vascular complications in the course of treatment of bronchial asthma with sympathomimetic amines. Przeglad Lekarski 30(7): 564-568, 1973

Sympathomimetic drugs and bronchial asthma. Medical Journal of Australia 2(17): 752, 1968

The effect of a new sympathomimetic beta-receptor stimulating drug (terbutaline) on arterial blood gases in bronchial sthma. Scandinavian Journal of Respiratory Diseases 51(3): 212-217, 1970

Sympathomimetic and non sympathomimetic stimulant effects of beta adrenergic blocking agents on isolated heart muscle abstract kitten. Pharmacologist 9(2): 248, 1967

Dose response trial of additive effects of a beta 2 sympathomimetic and an anti cholinergic drug in allergic asthma. Atemwegs-und Lungenkrankheiten 7(2): 57-65, 1981